A citation-based method for searching scientific literature

Fu-Chun Zhou, Joseph W Y Lee, Qi-Hang Zhang, Zuo-Li Sun, Qijing Bo, Xiao-Xiao He, Tian Han, Min Xiong, Chaohui Li, Chuan-Yue Wang. Schizophr Bull 2020
Times Cited: 2







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Genetically predicted complement component 4A expression: effects on memory function and middle temporal lobe activation.
G Donohoe, J Holland, D Mothersill, S McCarthy-Jones, D Cosgrove, D Harold, A Richards, K Mantripragada, M J Owen, M C O'Donovan,[...]. Psychol Med 2018
17
50

C4A mRNA expression in PBMCs predicts the presence and severity of delusions in schizophrenia and bipolar disorder with psychosis.
Jennifer K Melbourne, Cherise Rosen, Benjamin Feiner, Rajiv P Sharma. Schizophr Res 2018
10
50

Developmental activities of the complement pathway in migrating neurons.
Anna Gorelik, Tamar Sapir, Rebecca Haffner-Krausz, Tsviya Olender, Trent M Woodruff, Orly Reiner. Nat Commun 2017
48
50

Increased synapse elimination by microglia in schizophrenia patient-derived models of synaptic pruning.
Carl M Sellgren, Jessica Gracias, Bradley Watmuff, Jonathan D Biag, Jessica M Thanos, Paul B Whittredge, Ting Fu, Kathleen Worringer, Hannah E Brown, Jennifer Wang,[...]. Nat Neurosci 2019
199
50

Baseline high levels of complement component 4 predict worse clinical outcome at 1-year follow-up in first-episode psychosis.
Valeria Mondelli, Marta Di Forti, B Paul Morgan, Robin M Murray, Carmine M Pariante, Paola Dazzan. Brain Behav Immun 2020
13
50

The complement system in schizophrenia: where are we now and what's next?
Julia J Woo, Jennie G Pouget, Clement C Zai, James L Kennedy. Mol Psychiatry 2020
34
50

Acute phase proteins in schizophrenia, mania and major depression: modulation by psychotropic drugs.
M Maes, J Delange, R Ranjan, H Y Meltzer, R Desnyder, W Cooremans, S Scharpé. Psychiatry Res 1997
252
50

Complement system biomarkers in first episode psychosis.
Maja Kopczynska, Wioleta Zelek, Samuel Touchard, Fiona Gaughran, Marta Di Forti, Valeria Mondelli, Robin Murray, Michael C O'Donovan, B Paul Morgan. Schizophr Res 2019
30
50

Complement factors in newly diagnosed Nigerian schizoprenic patients and those on antipsychotic therapy.
O B Idonije, K S Akinlade, O Ihenyen, O G Arinola. Niger J Physiol Sci 2012
10
50

CSF biomarkers of Alzheimer's disease concord with amyloid-β PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts.
Oskar Hansson, John Seibyl, Erik Stomrud, Henrik Zetterberg, John Q Trojanowski, Tobias Bittner, Valeria Lifke, Veronika Corradini, Udo Eichenlaub, Richard Batrla,[...]. Alzheimers Dement 2018
200
50

Investigation of peripheral complement factors across stages of psychosis.
Liliana Laskaris, Andrew Zalesky, Cynthia Shannon Weickert, Maria A Di Biase, Gursharan Chana, Bernhard T Baune, Chad Bousman, Barnaby Nelson, Patrick McGorry, Ian Everall,[...]. Schizophr Res 2019
25
50


Complement genes contribute sex-biased vulnerability in diverse disorders.
Nolan Kamitaki, Aswin Sekar, Robert E Handsaker, Heather de Rivera, Katherine Tooley, David L Morris, Kimberly E Taylor, Christopher W Whelan, Philip Tombleson, Loes M Olde Loohuis,[...]. Nature 2020
55
50

Age and Sex-Associated Changes of Complement Activity and Complement Levels in a Healthy Caucasian Population.
Mariana Gaya da Costa, Felix Poppelaars, Cees van Kooten, Tom E Mollnes, Francesco Tedesco, Reinhard Würzner, Leendert A Trouw, Lennart Truedsson, Mohamed R Daha, Anja Roos,[...]. Front Immunol 2018
79
50

Schizophrenia risk from complex variation of complement component 4.
Aswin Sekar, Allison R Bialas, Heather de Rivera, Avery Davis, Timothy R Hammond, Nolan Kamitaki, Katherine Tooley, Jessy Presumey, Matthew Baum, Vanessa Van Doren,[...]. Nature 2016
50

Dose Equivalents for Antipsychotic Drugs: The DDD Method.
Stefan Leucht, Myrto Samara, Stephan Heres, John M Davis. Schizophr Bull 2016
163
50

C3 and C4 are strongly related to adipose tissue variables and cardiovascular risk factors.
Bo Nilsson, Osama A Hamad, Håkan Ahlström, Joel Kullberg, Lars Johansson, Lars Lindhagen, Arvo Haenni, Kristina N Ekdahl, Lars Lind. Eur J Clin Invest 2014
50
50

Mechanisms of ketamine action as an antidepressant.
P Zanos, T D Gould. Mol Psychiatry 2018
249
50

Acid sphingomyelinase-ceramide system mediates effects of antidepressant drugs.
Erich Gulbins, Monica Palmada, Martin Reichel, Anja Lüth, Christoph Böhmer, Davide Amato, Christian P Müller, Carsten H Tischbirek, Teja W Groemer, Ghazaleh Tabatabai,[...]. Nat Med 2013
196
50

Implications of the DSM's emphasis on sadness and anhedonia in major depressive disorder.
Julia D Buckner, Thomas E Joiner, Jeremy W Pettit, Peter M Lewinsohn, Norman B Schmidt. Psychiatry Res 2008
38
50

What Is New about New Antidepressants?
Steven L Dubovsky. Psychother Psychosom 2018
22
50


The effect of simvastatin treatment on behavioral parameters, cognitive performance, and hippocampal morphology in rats fed a standard or a high-fat diet.
Özgür Devrim Can, Emel Ulupınar, Ümide Demir Özkay, Bengi Yegin, Yusuf Öztürk. Behav Pharmacol 2012
40
50


Hyperlipidemia, statin use and the risk of developing depression: a nationwide retrospective cohort study.
Chieh-Sen Chuang, Tse-Yen Yang, Chih-Hsin Muo, Hong-Lin Su, Fung-Chang Sung, Chia-Hung Kao. Gen Hosp Psychiatry 2014
32
50

Higher baseline interleukin-1β and TNF-α hamper antidepressant response in major depressive disorder.
Francesco Benedetti, Sara Poletti, Benedetta Vai, Mario Gennaro Mazza, Cristina Lorenzi, Silvia Brioschi, Veronica Aggio, Igor Branchi, Cristina Colombo, Roberto Furlan,[...]. Eur Neuropsychopharmacol 2021
4
50

Lipid-lowering drugs and the risk of depression and suicidal behavior.
Chen-Chang Yang, Susan S Jick, Hershel Jick. Arch Intern Med 2003
85
50

Different cytokine patterns associate with melancholia severity among inpatients with major depressive disorder.
Lucas Primo de Carvalho Alves, Neusa Sica da Rocha. Ther Adv Psychopharmacol 2020
5
50

Altered peripheral blood compounds in drug-naïve first-episode patients with either schizophrenia or major depressive disorder: a meta-analysis.
Nuray Çakici, Arjen L Sutterland, Brenda W J H Penninx, Virgil A Dalm, Lieuwe de Haan, Nico J M van Beveren. Brain Behav Immun 2020
23
50

The Effect of Concomitant Treatment With SSRIs and Statins: A Population-Based Study.
Ole Köhler, Christiane Gasse, Liselotte Petersen, Katja G Ingstrup, Andrew A Nierenberg, Ole Mors, Søren D Østergaard. Am J Psychiatry 2016
40
50


Lipidomic analyses of the mouse brain after antidepressant treatment: evidence for endogenous release of long-chain fatty acids?
Lynette Hui-Wen Lee, Guanghou Shui, Akhlaq A Farooqui, Markus R Wenk, Chay-Hoon Tan, Wei-Yi Ong. Int J Neuropsychopharmacol 2009
26
50

Anti-inflammatory treatment and risk for depression after first-time stroke in a cohort of 147 487 Danish patients.
Ida Kim Wium-Andersen, Marie Kim Wium-Andersen, Martin Balslev Jørgensen, Merete Osler. J Psychiatry Neurosci 2017
19
50




Lovastatin potentiates the antidepressant efficacy of fluoxetine in rats.
Perry F Renshaw, Aram Parsegian, C Kevin Yang, Aileen Novero, Sujung J Yoon, In Kyoon Lyoo, Bruce M Cohen, William A Carlezon. Pharmacol Biochem Behav 2009
22
50

Statin treatment and the risk of depression.
Ole Köhler-Forsberg, Christiane Gasse, Liselotte Petersen, Andrew A Nierenberg, Ole Mors, Søren Dinesen Østergaard. J Affect Disord 2019
12
50

A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers.
Charles L Raison, Robin E Rutherford, Bobbi J Woolwine, Chen Shuo, Pamela Schettler, Daniel F Drake, Ebrahim Haroon, Andrew H Miller. JAMA Psychiatry 2013
883
50


Atorvastatin and Fluoxetine Prevent Oxidative Stress and Mitochondrial Dysfunction Evoked by Glutamate Toxicity in Hippocampal Slices.
Fabiana K Ludka, Tharine Dal-Cim, Luisa Bandeira Binder, Leandra Celso Constantino, Caio Massari, Carla I Tasca. Mol Neurobiol 2017
19
50

Atorvastatin prevents lipopolysaccharide-induced depressive-like behaviour in mice.
E H Taniguti, Y S Ferreira, I J V Stupp, E B Fraga-Junior, D L Doneda, L Lopes, F Rios-Santos, E Lima, Z S Buss, G G Viola,[...]. Brain Res Bull 2019
26
50

The role of NMDA receptor in neurobiology and treatment of major depressive disorder: Evidence from translational research.
Meysam Amidfar, Marie Woelfer, Gislaine Z Réus, João Quevedo, Martin Walter, Yong-Ku Kim. Prog Neuropsychopharmacol Biol Psychiatry 2019
23
50


In a randomized, double-blind clinical trial, adjuvant atorvastatin improved symptoms of depression and blood lipid values in patients suffering from severe major depressive disorder.
Mohammad Haghighi, Saeed Khodakarami, Leila Jahangard, Mohammad Ahmadpanah, Hafez Bajoghli, Edith Holsboer-Trachsler, Serge Brand. J Psychiatr Res 2014
39
50

A prospective study of statin use and poststroke depression.
Jae-Min Kim, Robert Stewart, Hee-Ju Kang, Kyung-Yeol Bae, Sung-Wan Kim, Il-Seon Shin, Joon-Tae Kim, Man-Seok Park, Ki-Hyun Cho, Jin-Sang Yoon. J Clin Psychopharmacol 2014
23
50

No Impact of Preadmission Anti-Inflammatory Drug Use on Risk of Depression and Anxiety After Critical Illness.
Clara R Medici, Jaimie L Gradus, Lars Pedersen, Henrik T Sørensen, Søren D Østergaard, Christian F Christiansen. Crit Care Med 2017
6
50

Health-related quality of life and long-term therapy with pravastatin and tocopherol (vitamin E) in older adults.
Cynthia M Carlsson, Kristi Papcke-Benson, Molly Carnes, Patrick E McBride, James H Stein. Drugs Aging 2002
26
50

Statins for major depressive disorder: A systematic review and meta-analysis of randomized controlled trials.
Riccardo De Giorgi, Franco De Crescenzo, Nicola Rizzo Pesci, Marieke Martens, Wendy Howard, Philip J Cowen, Catherine J Harmer. PLoS One 2021
5
50

Role of Adiposity-Driven Inflammation in Depressive Morbidity.
Lucile Capuron, Julie Lasselin, Nathalie Castanon. Neuropsychopharmacology 2017
67
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.